Md Nurunnabi to Mice
This is a "connection" page, showing publications Md Nurunnabi has written about Mice.
Connection Strength
1.291
-
Diwan R, Bhatt HN, Dong R, Estevao IL, Varela-Ramirez A, Nurunnabi M. Cell selective BCL-2 inhibition enabled by lipid nanoparticles alleviates lung fibrosis. J Control Release. 2024 Jun; 370:421-437.
Score: 0.111
-
Bhatt HN, Diwan R, Estevao IL, Dong R, Smith J, Xiao C, Agarwal SK, Nurunnabi M. Cadherin-11 targeted cell-specific liposomes enabled skin fibrosis treatment by inducing apoptosis. J Control Release. 2024 Jun; 370:110-123.
Score: 0.111
-
Kumar R, Afrin H, Bhatt HN, Beaven E, Gangavarap A, Esquivel SV, Zahid MI, Nurunnabi M. Mucoadhesive Carrier-Mediated Oral Co-delivery of Bcl2 Inhibitors Improves Gastric Cancer Treatment. ACS Appl Mater Interfaces. 2024 Jan 10; 16(1):305-317.
Score: 0.108
-
Bhatt HN, Diwan R, Borrego EA, P?rez CAM, Varela-Ramirez A, Kumar R, Aguilera RJ, Nurunnabi M. A photothermal driven chemotherapy for the treatment of metastatic melanoma. J Control Release. 2023 09; 361:314-333.
Score: 0.105
-
Afrin H, Esquivel SV, Kumar R, Zahid MI, Oporeza B, Rahman MF, Boland T, Nurunnabi M. ?-Glucan-Mediated Oral Codelivery of 5FU and Bcl2 siRNA Attenuates Stomach Cancer. ACS Appl Mater Interfaces. 2023 Jul 12; 15(27):32188-32200.
Score: 0.104
-
Esquivel SV, Bhatt HN, Diwan R, Habib A, Lee WY, Khatun Z, Nurunnabi M. ?-Glucan and Fatty Acid Based Mucoadhesive Carrier for Gastrointestinal Tract Specific Local and Sustained Drug Delivery. Biomolecules. 2023 04 28; 13(5).
Score: 0.103
-
Huda MN, Deaguero IG, Borrego EA, Kumar R, Islam T, Afrin H, Varela-Ramirez A, Aguilera RJ, Tanner EEL, Nurunnabi M. Ionic liquid-mediated delivery of a BCL-2 inhibitor for topical treatment of skin melanoma. J Control Release. 2022 09; 349:783-795.
Score: 0.098
-
Chowdhury AS, Geetha Bai R, Islam T, Abir M, Narayan M, Khatun Z, Nurunnabi M. Bile acid linked ?-glucan nanoparticles for liver specific oral delivery of biologics. Biomater Sci. 2022 May 31; 10(11):2929-2939.
Score: 0.097
-
Nurunnabi M, Lee SA, Revuri V, Hwang YH, Kang SH, Lee M, Cho S, Cho KJ, Byun Y, Bae YH, Lee DY, Lee YK. Oral delivery of a therapeutic gene encoding glucagon-like peptide 1 to treat high fat diet-induced diabetes. J Control Release. 2017 Dec 28; 268:305-313.
Score: 0.070
-
Nurunnabi M, Khatun Z, Reeck GR, Lee DY, Lee YK. Photoluminescent graphene nanoparticles for cancer phototherapy and imaging. ACS Appl Mater Interfaces. 2014 Aug 13; 6(15):12413-21.
Score: 0.056
-
Nurunnabi M, Khatun Z, Nafiujjaman M, Lee DG, Lee YK. Surface coating of graphene quantum dots using mussel-inspired polydopamine for biomedical optical imaging. ACS Appl Mater Interfaces. 2013 Aug 28; 5(16):8246-53.
Score: 0.053
-
Nurunnabi M, Khatun Z, Huh KM, Park SY, Lee DY, Cho KJ, Lee YK. In vivo biodistribution and toxicology of carboxylated graphene quantum dots. ACS Nano. 2013 Aug 27; 7(8):6858-67.
Score: 0.052
-
Nurunnabi M, Khatun Z, Reeck GR, Lee DY, Lee YK. Near infra-red photoluminescent graphene nanoparticles greatly expand their use in noninvasive biomedical imaging. Chem Commun (Camb). 2013 Jun 04; 49(44):5079-81.
Score: 0.052
-
Nurunnabi M, Cho KJ, Choi JS, Huh KM, Lee YK. Targeted near-IR QDs-loaded micelles for cancer therapy and imaging. Biomaterials. 2010 Jul; 31(20):5436-44.
Score: 0.042
-
Knipe RS, Nurunnabi M, Probst CK, Spinney JJ, Abe E, Bose RJC, Ha K, Logue A, Nguyen T, Servis R, Drummond M, Haring A, Brazee PL, Medoff BD, McCarthy JR. Myofibroblast-specific inhibition of the Rho kinase-MRTF-SRF pathway using nanotechnology for the prevention of pulmonary fibrosis. Am J Physiol Lung Cell Mol Physiol. 2023 02 01; 324(2):L190-L198.
Score: 0.025
-
Gonzalez MA, Olivas IM, Bencomo-Alvarez AE, Rubio AJ, Barreto-Vargas C, Lopez JL, Dang SK, Solecki JP, McCall E, Astudillo G, Velazquez VV, Schenkel K, Reffell K, Perkins M, Nguyen N, Apaflo JN, Alvidrez E, Young JE, Lara JJ, Yan D, Senina A, Ahmann J, Varley KE, Mason CC, Eide CA, Druker BJ, Nurunnabi M, Padilla O, Bajpeyi S, Eiring AM. Loss of G0/G1 switch gene 2 (G0S2) promotes disease progression and drug resistance in chronic myeloid leukaemia (CML) by disrupting glycerophospholipid metabolism. Clin Transl Med. 2022 12; 12(12):e1146.
Score: 0.025
-
Lee DY, Nurunnabi M, Kang SH, Nafiujjaman M, Huh KM, Lee YK, Kim YC. Oral Gavage Delivery of PR8 Antigen with ?-Glucan-Conjugated GRGDS Carrier to Enhance M-Cell Targeting Ability and Induce Immunity. Biomacromolecules. 2017 04 10; 18(4):1172-1179.
Score: 0.017
-
Muthiah M, Park SH, Nurunnabi M, Lee J, Lee YK, Park H, Lee BI, Min JJ, Park IK. Intracellular delivery and activation of the genetically encoded photosensitizer Killer Red by quantum dots encapsulated in polymeric micelles. Colloids Surf B Biointerfaces. 2014 Apr 01; 116:284-94.
Score: 0.014
-
Khatun Z, Nurunnabi M, Reeck GR, Cho KJ, Lee YK. Oral delivery of taurocholic acid linked heparin-docetaxel conjugates for cancer therapy. J Control Release. 2013 Aug 28; 170(1):74-82.
Score: 0.013
-
Khatun Z, Nurunnabi M, Cho KJ, Lee YK. Oral delivery of near-infrared quantum dot loaded micelles for noninvasive biomedical imaging. ACS Appl Mater Interfaces. 2012 Aug; 4(8):3880-7.
Score: 0.012
-
Khatun Z, Nurunnabi M, Cho KJ, Lee YK. Imaging of the GI tract by QDs loaded heparin-deoxycholic acid (DOCA) nanoparticles. Carbohydr Polym. 2012 Nov 06; 90(4):1461-8.
Score: 0.012
-
Kim JS, Cho KJ, Tran TH, Nurunnabi M, Moon TH, Hong SM, Lee YK. In vivo NIR imaging with CdTe/CdSe quantum dots entrapped in PLGA nanospheres. J Colloid Interface Sci. 2011 Jan 15; 353(2):363-71.
Score: 0.011